Ashley Krotchen, the head of Eli Lilly Austria, demands more predictability and faster access to clinical studies and innovations, as the domestic pharmaceutical location is falling behind in international competition and access to new therapies is often delayed. #klinischeStudien #Pharmaforschung #Österreich (translated)


